查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1990115

消费者基因组学市场：2026-2032年全球市场预测（按产品类型、技术、测试类型、应用和最终用户划分）

Consumer Genomics Market by Product Type, Technology, Test Type, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，消费者基因组学市场价值将达到 30.2 亿美元，到 2026 年将成长至 36.6 亿美元，到 2032 年将达到 125.6 亿美元，复合年增长率为 22.54%。

主要市场统计数据
基准年 2025 30.2亿美元
预计年份：2026年 36.6亿美元
预测年份 2032 125.6亿美元
复合年增长率 (%) 22.54%

权威地介绍了不断发展的消费者基因组学生态系统以及塑造商业性和临床路径的融合力量。

消费者基因组学领域正处于一个关键的十字路口，科学创新、商业性雄心和社会关切以日益复杂的方式交织在一起。定序技术的最新进展，结合更先进的生物资讯学，降低了技术进入门槛，将消费者基因服务的范围从祖源追溯扩展到健康、药物基因体学和生活方式应用。这种扩张是由消费者对预防医学和个人化健康日益增长的兴趣所驱动的，这使得他们需要能够提供可操作且可解读的见解的检测，而不仅仅是原始数据。

人工智慧驱动的分析、多体学整合、不断发展的监管标准以及不断变化的消费者期望如何重新定义基因组学领域的竞争优势。

消费者基因组学领域正经历一系列变革性变化，这些变化正在重塑其能力和竞争动态。人工智慧和先进的机器学习技术正在改进对基因突变的解读，并实现更丰富的表型-基因型关联，从而提高消费者报告的临床相关性。定序技术的同步进步，尤其是在高通量平台和优化的样品製备，正在扩大消费者规模检测的准确性和范围。

评估近期关税变化对基因组产品跨境流动和商业化的多方面营运、策略和供应链影响。

2025年实施的关税调整的累积影响，正为依赖跨境分销设备、试剂和特殊组件的公司带来一系列复杂的营运和策略后果。关税上调提高了进口定序设备和某些耗材的接收成本，迫使供应链管理人员重新评估筹资策略。随着企业努力降低关税波动和运输延误的风险，这加速了关于供应商多元化和关键投入品近岸外包的讨论。

详细的细分洞察，清楚地展示了产品类型、技术、测试变化、应用和最终用户需求如何独特地影响策略重点和价值主张。

按产品类型进行的详细分析揭示了策略重点和商业性趋势的差异。试剂、试剂盒和定序耗材等耗材由于需要重复采购，因此需要检测化学方面的持续创新和可靠的供应。分析仪和定序仪等仪器需要长期支援模式、现场服务安排和资金筹措方案，以降低检查室和机构客户的采用门槛。服务，包括直接面向消费者的检测和专业检测服务，需要不同的客户参与模式。前者强调使用者体验和报告清晰度，而后者则优先考虑临床相关性和互通性。包括数据分析工具和报告平台在内的软体产品，在提供解读价值和支援后续临床操作方面正发挥越来越重要的作用。

区域比较分析解释了监管复杂性、基础设施成熟度和消费者行为如何塑造差异化的部署和伙伴关係策略。

区域趋势影响全球消费者基因组学产业的采纳路径、监管互动和合作机会。在美洲，成熟的直接面向消费者市场、强劲的私人投资以及充满活力的临床研究生态系统共同促进了产品的快速改进和多元化的经营模式。在监管方面，消费者保护和检查室标准至关重要，而关于保险报销的讨论在临床基因检测这一细分领域也变得日益重要。

企业策略和竞争方法展示了垂直整合、临床伙伴关係和资料管治如何创造差异化和长期竞争优势。

消费者基因组学生态系统中的主要企业正并行推行多项策略，以维持并扩大其竞争优势。这些策略包括：透过整合侦测能力和软体平台深化垂直整合；管理端到端的客户体验；以及透过订阅服务确保持续收入。此外，他们还利用与临床实验室、保险公司和研究机构的策略合作伙伴关係，验证临床效用，并开闢报销管道，从而方便患者在医疗保健系统内获得特定检测服务。

领导者可采取切实可行的策略步骤，以提高临床可靠性、加强供应链并利用资料管理作为市场差异化优势。

产业领导者可以采取多项具体措施来管理结构性风险，同时最大限度地掌握新机会。首先，他们可以透过调整产品蓝图，优先发展那些具有明确临床或行为学相关人员的测试和服务，来加强与临床合作伙伴和保险公司利害关係人的关係。其次，他们可以投资健全的资料管理实践，超越合规要求，建立信任，进而打造市场差异化优势。这包括透明的知情同意模式、可互通的数据标准以及严格的网路安全措施。

调查方法详细介绍了为确保获得稳健且符合伦理的见解和检验的研究结果而采用的混合方法、专家访谈和检验实践。

本分析采用混合方法，结合质性和量性调查方法，旨在得出严谨且可操作的见解。主要研究包括对测试营运、研发领导、法规事务和商业化团队等领域的产业从业人员进行结构化访谈，并辅以临床和政策顾问的专家咨询。次要研究则纳入了同行评审文献、监管指南、技术白皮书和公开的技术文件，并基于检验的证据进行分析。

结论强调，保持可持续的领导地位需要科学创新和临床检验、健全的管治以及适应性强的商业策略相结合。

总而言之，消费者基因体学领域正处于技术潜力和实际限制的交会点，蕴藏着影响预防医学、个人化治疗和消费者健康的巨大机会。儘管定序、生物资讯学和解读演算法的进步正在带来更多可操作的结果，但商业性的成功需要一种综合方法，将临床检验、可靠的数据管理和适应性供应链管理相结合。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：消费者基因体学市场：依产品类型划分

  • 消耗品
    • 试剂和试剂盒
    • 耗材定序
  • 装置
    • 分析器
    • 序列器
  • 服务
    • 面向一般消费者的测试
    • 专业测试服务
  • 软体
    • 数据分析工具
    • 报告创建软体

第九章：消费者基因体学市场：依技术划分

  • 生物资讯学和计算工具
  • CRISPR技术
  • DNA定序
  • 微阵列技术
  • 次世代定序
  • 聚合酵素链锁反应
  • 单核苷酸多态性（SNP）基因型鉴定

第十章：消费者基因体学市场测试的类型

  • 祖源搜寻
  • 基因带原检测
  • 营养基因体学检测
  • 肿瘤科检查
    • 癌症风险评估
    • 肿瘤DNA分析
  • 预测性和无症状检测

第十一章 消费者基因体学市场：依应用领域划分

  • 祖源与根源分析
  • 携带者筛检
  • 订製护肤和化妆品
  • 疾病预防与管理
  • 健康与保健
  • 生活方式和个人特征
  • 微生物组分析
  • 亲子关係与家庭关係
  • 药物基因体学

第十二章 消费者基因体学市场：依最终用户划分

  • 学术和研究机构
  • 生技公司
  • 健康与健康中心
  • 製药公司

第十三章 消费者基因体学市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 消费者基因体学市场：依群体划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 消费者基因体学市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国消费者基因体学市场

第十七章：中国消费者基因体学市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 10x Genomics, Inc.
  • 23andMe, Inc.
  • Agilent Technologies, Inc.
  • Ambry Genetics Corporation by Konica Minolta, Inc.
  • Ancestry
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Color Health, Inc.
  • Dante Labs Inc.
  • Decode Genetics by Amgen Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Full Genomes Corporation, Inc.
  • Gene by Gene, Ltd.
  • Helix, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • LetsGetChecked, Inc.
  • Living DNA Ltd
  • MyHeritage Ltd.
  • Nebula Genomics, Inc. by ProPhase Labs, Inc.
  • Oxford Nanopore Technologies PLC
  • QIAGEN GmbH
  • SeqLL Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-5D693B46C019

The Consumer Genomics Market was valued at USD 3.02 billion in 2025 and is projected to grow to USD 3.66 billion in 2026, with a CAGR of 22.54%, reaching USD 12.56 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.02 billion
Estimated Year [2026] USD 3.66 billion
Forecast Year [2032] USD 12.56 billion
CAGR (%) 22.54%

An authoritative introduction to the evolving consumer genomics ecosystem and the converging forces shaping commercial and clinical pathways

The consumer genomics landscape is at a pivotal juncture where scientific innovation, commercial ambition, and societal concerns intersect in increasingly complex ways. Recent advances in sequencing technologies, coupled with more sophisticated bioinformatics, have lowered technical barriers to entry and expanded the scope of consumer-facing genetic services beyond ancestry into health, pharmacogenomics, and lifestyle applications. This expansion has been accompanied by rising consumer interest in preventive health and personalized wellness, driving demand for tests that promise actionable, interpretable insights rather than raw data alone.

Concurrently, the industry faces intensifying scrutiny around data privacy, consent models, and the ethical use of genomic information. Regulators, payers, and clinical stakeholders are pushing for clearer evidence of clinical utility and standardized reporting formats that support integration into care pathways. Industry participants are responding by strengthening clinical validation, investing in secure data architectures, and collaborating with healthcare systems to demonstrate value.

Looking forward, sustained progress will hinge on the ability of providers to balance consumer expectations for convenience and affordability with robust governance, transparent value propositions, and clinically relevant outcomes. Strategic alignment across R&D, commercialization, and policy engagement will determine which organizations convert present opportunity into enduring leadership.

How AI driven interpretation, multi-omic integration, evolving regulatory standards, and shifting consumer expectations are redefining competitive advantage in genomics

The landscape of consumer genomics is being reshaped by a cluster of transformative shifts that are altering both capability and competitive dynamics. Artificial intelligence and advanced machine learning are enhancing variant interpretation and enabling richer phenotype-genotype correlations, which in turn improve the clinical relevance of consumer-facing reports. Parallel improvements in sequencing technologies, especially higher-throughput platforms and optimized library preparations, are increasing the fidelity and scope of tests that can be delivered at consumer scale.

Moreover, gene-editing advances and broader multi-omic integration are expanding the conceptual boundaries of what consumer genomics can inform, moving the industry from single-test outputs toward interconnected biological insights. Regulatory regimes are evolving in response, prompting companies to refine consent frameworks, strengthen data provenance controls, and seek partnerships with clinical laboratories and healthcare systems to validate utility. At the same time, consumer expectations are maturing: buyers increasingly favor services that offer clear actionability, ongoing care pathways, and transparent data practices rather than one-time reports.

These shifts are producing a market environment where agility in technology adoption, credibility in clinical validation, and trustworthiness in data stewardship are now core competitive differentiators. Organizations that can integrate these elements while maintaining operational efficiency will secure the strongest positions for sustained growth.

Assessing the multifaceted operational, strategic, and supply chain consequences of recent tariff changes on cross-border genomics product flows and commercialization

The cumulative effects of tariff changes enacted in 2025 have imposed a complex set of operational and strategic consequences for companies that rely on cross-border flows of instruments, reagents, and specialized components. Supply chain managers have had to reassess sourcing strategies as increased duties raise landed costs for imported sequencing instruments and certain consumables. This has accelerated conversations around supplier diversification and nearshoring for critical inputs, as organizations seek to reduce exposure to tariff volatility and transit-related delays.

These trade policy shifts have also influenced commercial decision-making. Some providers have absorbed incremental costs to preserve price competitiveness, while others have adjusted service tiers and bundling strategies to offset margin compression. In parallel, procurement teams have intensified vendor consolidation efforts in order to negotiate more favorable terms and to secure priority allocation of constrained items. Regulatory compliance and customs documentation requirements have also increased administrative burden, prompting investments in trade compliance capabilities and expanded coordination between commercial and logistics functions.

Longer term, the tariff environment has stimulated localized manufacturing initiatives and strategic partnerships with regional suppliers. While these adaptations can mitigate risk and shorten lead times, they require capital reallocation and time to build capacity. As a result, organizations that proactively redesign supply networks, lock in strategic supplier relationships, and align inventory strategies with regulatory and market signals will be better positioned to manage the downstream effects of trade policy changes.

Detailed segmentation insights that articulate how product types, technologies, test variations, applications, and end-user demands uniquely influence strategic priorities and value delivery

A granular view across product types reveals differentiated strategic priorities and commercial dynamics. Consumables, including reagents, kits, and sequencing consumables, demand continuous innovation in assay chemistry and supply reliability, given the recurring nature of purchases. Instruments such as analyzers and sequencers require long-term support models, field service capabilities, and financing options that lower adoption friction for laboratory and institutional customers. Services span direct-to-consumer tests and professional testing services, each requiring distinct customer engagement models: the former focuses on user experience and report clarity, while the latter emphasizes clinical validity and interoperability. Software offerings, including data analysis tools and report generation platforms, are increasingly central to delivering interpretive value and enabling downstream clinical action.

On the technology axis, bioinformatics and computational tools are essential for scalable interpretation, while DNA sequencing and next-generation sequencing serve as foundational laboratory modalities. Polymerase chain reaction remains indispensable for targeted assays, and single nucleotide polymorphism genotyping supports cost-effective screening use cases. Emerging technologies such as CRISPR-based assays and microarray platforms offer specialized capabilities that can complement mainstream sequencing approaches.

Test type segmentation highlights the diversity of consumer interest: ancestry testing continues to attract curiosity-led demand, carrier and predictive testing target reproductive planning and preventive care, nutrigenomics and lifestyle assessments appeal to wellness-oriented consumers, and oncology testing focuses on both cancer risk assessment and tumor DNA analysis with direct clinical implications. Applications range from ancestry and heritage analysis to pharmacogenomics and microbiome analysis, each with unique evidentiary and regulatory expectations.

End-users encompass academic and research institutes that require high-throughput solutions, biotechnology companies focused on R&D pipelines, health and wellness centers building consumer programs, and pharmaceutical companies leveraging genomic insights for drug development and patient stratification. Recognizing these distinctions enables firms to prioritize investments, tailor commercialization models, and design differentiated service levels that meet the nuanced needs of each segment.

Comparative regional intelligence describing how regulatory complexity, infrastructure maturity, and consumer behaviors shape differentiated adoption and partnership strategies

Regional dynamics shape adoption pathways, regulatory interactions, and partnership opportunities across the global consumer genomics industry. In the Americas, a combination of mature direct-to-consumer markets, robust private investment, and active clinical research ecosystems has promoted rapid product iteration and diverse commercial models. Regulatory focus emphasizes consumer protection and laboratory standards, and reimbursement discussions are increasingly relevant in clinical genetic testing niches.

Across Europe, the Middle East, and Africa, regulatory heterogeneity and data protection frameworks such as strong privacy regimes influence how companies approach cross-border data flows and localized operations. Public healthcare systems in parts of Europe create pathways for clinical integration when tests demonstrate utility, while in other regional markets private pay and out-of-pocket models predominate. Data localization requirements and variable laboratory infrastructure necessitate flexible operating models and partnerships with regional clinical laboratories.

The Asia-Pacific region is characterized by rapid adoption curves, significant investment in local manufacturing and genomics capacity, and a wide spectrum of regulatory maturity. High population density and large cohorts offer compelling opportunities for population-scale studies and personalized medicine initiatives, while rising consumer health awareness fuels demand for ancestry, wellness, and pharmacogenomic services. Across all regions, successful market entry depends on aligning offerings with local regulatory expectations, establishing trusted clinical and distribution partners, and adapting consumer engagement strategies to cultural norms and health literacy levels.

Corporate strategy and competitive approaches illustrating how vertical integration, clinical partnerships, and data governance drive differentiation and long-term advantage

Leading organizations in the consumer genomics ecosystem are pursuing several concurrent strategies to protect and extend competitive advantage. They are deepening vertical integration by combining laboratory capabilities with software platforms to control the end-to-end customer experience and to capture recurring revenue through subscription services. Strategic collaborations with clinical laboratories, payers, and research institutions are being used to validate clinical utility and to open reimbursement pathways that make certain tests more accessible within healthcare systems.

Investment in data governance and cyber resilience has become a strategic priority, with companies implementing stronger consent frameworks, encryption standards, and auditability to maintain trust with consumers and institutional partners. At the same time, go-to-market strategies are diversifying: some players emphasize consumer-branding and direct engagement, while others focus on enterprise and clinical channels that deliver scale through institutional adoption. R&D portfolios are balancing incremental assay improvements with platform-level investments in automation, AI-driven interpretation, and scalable reporting infrastructure.

Competitive differentiation is increasingly predicated on the ability to demonstrate validated outcomes, integrate seamlessly with clinical workflows, and offer transparent value propositions that align with payer and provider incentives. Organizations that combine these operational capabilities with disciplined commercial execution will be best positioned to win in both consumer and clinical domains.

Actionable strategic measures for leaders to strengthen clinical credibility, fortify supply chains, and leverage data stewardship as a market differentiator

Industry leaders can adopt several concrete actions to capitalize on emerging opportunities while managing structural risks. First, align product roadmaps to prioritize assays and services that demonstrate clear clinical or behavioral actionability, thereby strengthening relationships with clinical partners and payer stakeholders. Second, invest in robust data stewardship practices that go beyond compliance to establish trust as a market differentiator; this includes transparent consent models, interoperable data standards, and rigorous cybersecurity measures.

Third, redesign supply chain strategies to reduce exposure to geopolitical shocks and tariff volatility by diversifying suppliers, considering regional manufacturing partnerships, and maintaining strategic inventory buffers for critical consumables. Fourth, accelerate software and AI investments that enhance interpretive accuracy and enable scalable personalization, ensuring that algorithmic decisions are explainable and clinically validated. Fifth, tailor commercial approaches by segment: deliver streamlined user experiences for consumer channels while building evidence-driven value propositions for clinical and enterprise customers.

Finally, engage proactively with policymakers and standards bodies to shape pragmatic regulatory frameworks that balance innovation with consumer protection. By executing these steps, organizations will improve resilience, unlock new revenue streams, and create differentiated value for both consumers and clinical stakeholders.

Research methodology detailing mixed methods, expert consultations, and triangulation practices used to ensure robust, ethically grounded insights and validated findings

This analysis was developed through a mixed-methods approach combining qualitative and quantitative research techniques designed to produce rigorous, actionable insights. Primary research included structured interviews with industry practitioners across laboratory operations, R&D leadership, regulatory affairs, and commercialization teams, supplemented by expert consultations with clinical and policy advisors. Secondary research incorporated peer-reviewed literature, regulatory guidance, technology white papers, and publicly available technical documentation to ground the analysis in verifiable evidence.

Data synthesis emphasized triangulation across sources to validate thematic findings, while the segmentation framework guided targeted investigation into product types, technologies, test use cases, applications, and end-user needs. Care was taken to document assumptions and to identify areas where evidence is nascent, recommending further validation where appropriate. Quality assurance processes included methodological reviews, fact-checking, and iterative stakeholder feedback loops to refine conclusions and ensure relevance to decision-makers.

Ethical considerations were central to the research design, with attention to data privacy, potential conflicts of interest, and the responsible communication of scientific uncertainty. Limitations are acknowledged where available evidence is evolving rapidly, and recommended next steps include focused primary research and pilot studies to validate high-impact strategic hypotheses.

Conclusive synthesis highlighting the imperative to pair scientific innovation with clinical validation, robust governance, and adaptive commercial strategies for sustained leadership

In summary, the consumer genomics field stands at the intersection of technological possibility and real-world constraints, with substantial opportunity to influence preventive care, personalized treatment, and consumer wellness. Advancements in sequencing, bioinformatics, and interpretive algorithms are enabling more actionable outputs, but commercial success requires an integrated approach that couples clinical validation with trustworthy data practices and adaptive supply chain management.

Regulatory shifts and trade policy developments are reshaping operational imperatives, prompting investments in compliance, localized manufacturing, and strategic partnerships. Meanwhile, market segmentation points to differentiated value propositions across consumables, instruments, services, and software, and across technology, test type, application, and end-user dimensions. Companies that prioritize evidence of clinical utility, secure data stewardship, and seamless interoperability will find the most traction with healthcare systems and discerning consumers alike.

Ultimately, organizations that combine scientific rigor with pragmatic execution-focusing investments where they enable measurable clinical or behavioral impact-will convert current momentum into sustainable leadership. The path forward requires disciplined strategy, collaborative partnerships, and an unwavering commitment to responsible innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Consumer Genomics Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Reagents & Kits
    • 8.1.2. Sequencing Consumables
  • 8.2. Instruments
    • 8.2.1. Analyzers
    • 8.2.2. Sequencers
  • 8.3. Services
    • 8.3.1. Direct-to-Consumer Tests
    • 8.3.2. Professional Testing Services
  • 8.4. Software
    • 8.4.1. Data Analysis Tools
    • 8.4.2. Report Generation Software

9. Consumer Genomics Market, by Technology

  • 9.1. Bioinformatics & Computational Tools
  • 9.2. CRISPR Technology
  • 9.3. DNA Sequencing
  • 9.4. Microarray Technology
  • 9.5. Next-Generation Sequencing
  • 9.6. Polymerase Chain Reaction
  • 9.7. Single Nucleotide Polymorphism (SNP) Genotyping

10. Consumer Genomics Market, by Test Type

  • 10.1. Ancestry Testing
  • 10.2. Carrier Testing
  • 10.3. Nutrigenomics Testing
  • 10.4. Oncology Testing
    • 10.4.1. Cancer Risk Assessment
    • 10.4.2. Tumor DNA Analysis
  • 10.5. Predictive & Presymptomatic Testing

11. Consumer Genomics Market, by Application

  • 11.1. Ancestry & Heritage Analysis
  • 11.2. Carrier Screening
  • 11.3. Custom Skincare & Cosmetics
  • 11.4. Disease Prevention & Management
  • 11.5. Health & Wellness
  • 11.6. Lifestyle & Personal Traits
  • 11.7. Microbiome Analysis
  • 11.8. Paternity & Familial Relationships
  • 11.9. Pharmacogenomics

12. Consumer Genomics Market, by End-User

  • 12.1. Academic & Research Institutes
  • 12.2. Biotechnology Companies
  • 12.3. Health & Wellness Centers
  • 12.4. Pharmaceutical Companies

13. Consumer Genomics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Consumer Genomics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Consumer Genomics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Consumer Genomics Market

17. China Consumer Genomics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 10x Genomics, Inc.
  • 18.6. 23andMe, Inc.
  • 18.7. Agilent Technologies, Inc.
  • 18.8. Ambry Genetics Corporation by Konica Minolta, Inc.
  • 18.9. Ancestry
  • 18.10. BGI Group
  • 18.11. Bio-Rad Laboratories, Inc.
  • 18.12. Color Health, Inc.
  • 18.13. Dante Labs Inc.
  • 18.14. Decode Genetics by Amgen Inc.
  • 18.15. Eurofins Scientific SE
  • 18.16. F. Hoffmann-La Roche Ltd
  • 18.17. Full Genomes Corporation, Inc.
  • 18.18. Gene by Gene, Ltd.
  • 18.19. Helix, Inc.
  • 18.20. Illumina, Inc.
  • 18.21. Invitae Corporation
  • 18.22. LetsGetChecked, Inc.
  • 18.23. Living DNA Ltd
  • 18.24. MyHeritage Ltd.
  • 18.25. Nebula Genomics, Inc. by ProPhase Labs, Inc.
  • 18.26. Oxford Nanopore Technologies PLC
  • 18.27. QIAGEN GmbH
  • 18.28. SeqLL Inc.
  • 18.29. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONSUMER GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONSUMER GENOMICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CONSUMER GENOMICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CONSUMER GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CONSUMER GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CONSUMER GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SEQUENCING CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SEQUENCING CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SEQUENCING CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SEQUENCERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SEQUENCERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DIRECT-TO-CONSUMER TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DIRECT-TO-CONSUMER TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DIRECT-TO-CONSUMER TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PROFESSIONAL TESTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PROFESSIONAL TESTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PROFESSIONAL TESTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DATA ANALYSIS TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DATA ANALYSIS TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DATA ANALYSIS TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REPORT GENERATION SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REPORT GENERATION SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REPORT GENERATION SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY BIOINFORMATICS & COMPUTATIONAL TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY BIOINFORMATICS & COMPUTATIONAL TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY BIOINFORMATICS & COMPUTATIONAL TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CRISPR TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CRISPR TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CRISPR TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANCESTRY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANCESTRY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANCESTRY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CARRIER TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CARRIER TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CARRIER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY NUTRIGENOMICS TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY NUTRIGENOMICS TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY NUTRIGENOMICS TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CANCER RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CANCER RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CANCER RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY TUMOR DNA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY TUMOR DNA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY TUMOR DNA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PREDICTIVE & PRESYMPTOMATIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PREDICTIVE & PRESYMPTOMATIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PREDICTIVE & PRESYMPTOMATIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANCESTRY & HERITAGE ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANCESTRY & HERITAGE ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANCESTRY & HERITAGE ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CARRIER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CARRIER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CUSTOM SKINCARE & COSMETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CUSTOM SKINCARE & COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CUSTOM SKINCARE & COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DISEASE PREVENTION & MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DISEASE PREVENTION & MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DISEASE PREVENTION & MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY HEALTH & WELLNESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY HEALTH & WELLNESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY HEALTH & WELLNESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY LIFESTYLE & PERSONAL TRAITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY LIFESTYLE & PERSONAL TRAITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY LIFESTYLE & PERSONAL TRAITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY MICROBIOME ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY MICROBIOME ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY MICROBIOME ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PATERNITY & FAMILIAL RELATIONSHIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PATERNITY & FAMILIAL RELATIONSHIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PATERNITY & FAMILIAL RELATIONSHIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PHARMACOGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY HEALTH & WELLNESS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY HEALTH & WELLNESS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY HEALTH & WELLNESS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 230. GCC CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. GCC CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. GCC CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 233. GCC CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 234. GCC CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 235. GCC CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 236. GCC CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. GCC CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. GCC CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 239. GCC CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. GCC CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 263. G7 CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. G7 CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 266. G7 CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 267. G7 CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 268. G7 CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 269. G7 CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. G7 CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. G7 CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 272. G7 CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. G7 CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 274. NATO CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. NATO CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. NATO CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 277. NATO CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 278. NATO CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 279. NATO CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 280. NATO CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. NATO CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. NATO CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 283. NATO CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. NATO CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES CONSUMER GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA CONSUMER GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. CHINA CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)